This interview is part of a throwback mini-series to several years ago when I chatted with Kevin Bitterman, who at the time, was with Polaris Venture Partners. He’s now a partner with Atlas Venture, but the lessons you can glean from this discussion still hold true. Namely:

• What medtech venture capitalists like to see in a startup and how these early-stage medical device companies can best position themselves for success. 
• What requirements would make for an attractive IPO opportunity?
• What questions should medtech startups have already answered before approaching a potential buyer?
• And in terms of a potential exit, what is more, important for a medical device startup – clinical data or commercial traction?

See more...